{
  "id": "cluster_9_doc6",
  "content": "Email thread between Dr. Voss (elara.voss@mesaridge.org) and BlueShield medical director discusses TK4721's case. Attachments include tumor progression scans dated 03/01/2024 and LUMINA-4 eligibility confirmation. Multiple requests for expedited review referenced CRS-229M's hardship exception clause. Final approval granted 03/23/2024 with $142,000 in provider concessions.",
  "metadata": {
    "format": "insurance_memo"
  }
}